BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The offering is subject to market conditions, with the net proceeds to be used for purchasing gold bullion, working capital, and general corporate purposes.
Clear Street and Needham & Company are the joint book-running managers of the offering.
Offering Details
Shares of common stock (or pre-funded warrants) are being offered by BioSig Technologies, Inc. through an underwritten public offering.
Use of Proceeds
The net proceeds from the offering will be used for purchasing gold bullion, working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
- BioSig intends to purchase gold bullion, indicating a strategic investment move in alignment with its investment policy.
- The completion of the offering is contingent on market conditions, introducing uncertainty into the timing and terms of the offering.
BioSig Technologies' proposed public offering aims to raise funds for strategic purposes, with a focus on gold bullion acquisition and general corporate use.